(+) -Kavain
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(+) -Kavain
Description :
(+) -Kavain, a main kavalactone extracted from Piper methysticum, has anticonvulsive properties, attenuating vascular smooth muscle contraction through interactions with voltage-dependent Na+ and Ca2+ channels[1]. (+) -Kavain is shown to bind at the α4β2δ GABAA receptor and potentiate GABA efficacy[2]. (+) -Kavain is used as a treatment for inflammatory diseases, its anti-inflammatory action has been widely studied[4].CAS Number :
[500-64-1]UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Calcium Channel; GABA Receptor; Sodium ChannelType :
Natural ProductsRelated Pathways :
Membrane Transporter/Ion Channel; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Metabolic Disease; Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/__addition__-Kavain.htmlPurity :
99.98Solubility :
DMSO : 50 mg/mL (ultrasonic)Smiles :
O=C1C=C(OC)C[C@H](/C=C/C2=CC=CC=C2)O1Molecular Formula :
C14H14O3Molecular Weight :
230.26Precautions :
H302, H315, H319, H335References & Citations :
[1]Bradić I, et al. [Hirschsprung's disease -- therapy and results]. Acta Chir Iugosl. 1975;22 (2) :183-95.|[2]Chua HC, et al. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. PLoS One. 2016 Jun 22;11 (6) :e0157700.|[3]G. Boonen, et al. In vivo Effects of the Kavapyrones (+) -Dihydromethysticin and (±) -Kavain on Dopamine, 3,4-Dihydroxyphenylacetic Acid, Serotonin and 5-Hydroxyindoleacetic Acid Levels in Striatal and Cortical Brain Regions. Planta Medica 64 (1998) 507-510.|[4]Tang X, et al. Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF. Toxicol Res (Camb) . 2016 Jan 1;5 (1) :188-196.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture and light)Scientific Category :
Natural ProductsClinical Information :
No Development Reported

